Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Invest Clin ; 50(2): 153-61, 2009 Jun.
Artículo en Español | MEDLINE | ID: mdl-19662811

RESUMEN

Codon 72 polymorphism of the tumor suppressor gene TP53 has been associated with a higher risk in the development of several types of cancer. The polymorphism results in a variant protein with either an arginine (CGC) or a proline residue (CCC). The aim of this study was to analyze the association of the TP53 codon 72 polymorphism with the risk of developing gastric cancer in a high-risk population from the central-western region of Venezuela. DNA was extracted from paraffin-embedded gastric adenocarcinoma biopsies (n=65) and endoscopic biopsies from chronic gastritis patients (n=87). TP53 codon 72 polymorphism was determined by PCR-RFLP from all samples. Patients with gastric cancer had a significantly higher frequency (P = 0.037) of the Arg allele than those with chronic gastritis. A logistic regression analysis suggested that Arg carrier individuals had a 4.6-fold higher risk (95% CI 1.0-21.3) of developing gastric cancer. An increment of the Arg/Arg genotype was observed in poor-differentiated gastric adenocarcinoma (OR: 3.1; 95% CI 1.0-9.2), and of the Arg/Pro genotype in well/moderate-differentiated adenocarcinoma samples (OR: 3.5; 95% CI 1.1-11.0), when comparing within the gastric cancer samples; and the last group also when contrasting it with chronic gastritis patients (OR: 2.4; 95% CI 1.1-5.2). The results of this study suggest that the carriage of the Arg allele could be associated with the development of gastric cancer in this Venezuelan population.


Asunto(s)
Adenocarcinoma/genética , Codón/genética , Genes p53 , Polimorfismo de Nucleótido Simple , Neoplasias Gástricas/genética , Adenocarcinoma/epidemiología , Adenocarcinoma/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Alelos , Estudios de Casos y Controles , Diferenciación Celular , ADN de Neoplasias/genética , Femenino , Gastritis/epidemiología , Gastritis/genética , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Riesgo , Neoplasias Gástricas/epidemiología , Neoplasias Gástricas/patología , Venezuela/epidemiología , Adulto Joven
2.
Invest Clin ; 48(4): 485-93, 2007 Dec.
Artículo en Español | MEDLINE | ID: mdl-18271393

RESUMEN

Telomeres are nucleoprotein complexes that protect the ends of eucaryotic chromosomes from degradation and recombination. In humans, telomeres measure 10-12 kbp in normal somatic cells, but they scarcely reach 1-2 kbp in tumor cells of rapid growth, due to the incomplete replication of these structures in each mitotic division. Telomeres shorten with age, which can be associated to genomic instability and to an increment of the risk of suffering from cancer. The standard method to measure the telomere length is the analysis of telomeric restriction fragments by Southern blot. However, a precise determination is not possible when the DNA is broken into small fragments or if it is scarce. In this work, a slot blot assay was adapted to quantify the relative content, instead of the length, of telomeric DNA from paraffin-embedded archival specimens of colon adenocarcinoma. The telomeric DNA content could be reproducibly measured with hardly 75 ng of highly degraded genomic DNA by chemiluminescent detection for hybridization.


Asunto(s)
Adenocarcinoma/química , Neoplasias del Colon/química , ADN de Neoplasias/análisis , Mediciones Luminiscentes/métodos , Hibridación de Ácido Nucleico/métodos , Telómero/química , Adenocarcinoma/genética , Anciano , Anciano de 80 o más Años , Proteínas Bacterianas , Bancos de Muestras Biológicas , Biopsia , Biotinilación , Neoplasias del Colon/genética , Fragmentación del ADN , Electroforesis en Gel de Agar , Femenino , Peroxidasa de Rábano Silvestre , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Fijación del Tejido/métodos
3.
Arch Endocrinol Metab ; 60(3): 246-51, 2015 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-26201011

RESUMEN

OBJECTIVE: The global burden of diabetes mellitus will impact strongly American countries in the coming decades. Type 2 diabetes mellitus (T2DM) is a multifactorial disease and the basis for its genetic susceptibility remains not fully understood. Different population studies have demonstrated that variants of the TCF7L2 gene are strongly associated with an increased risk of T2DM. Moreover, institutions or countries with limited budget to conduct genetic research need cost effective methods for detecting DNA variants. SUBJECTS AND METHODS: We standardized a rapid and simple allele-specific PCR method for genotyping the rs12255372 single nucleotide polymorphism (SNP) in a pilot study exploring the association of three TCF7L2 polymorphisms (rs7903146, rs12255372 and DG10S478) with T2DM in 70 patients and 73 controls from Venezuela. RESULTS: The performance of the designed allele-specific PCR reaction for rs12255372 genotyping was reliable and accurate. Patients carrying the TCF7L2 rs7903146 T allele (CT + TT genotypes) and heterozygous CT genotype had a significantly higher risk for T2DM (OR = 2.9 and 2.3, respectively). Although rs12255372 and DG10S478 risk alleles predominated in T2DM group no statistical significance was found. CONCLUSIONS: We developed a novel allele-specific PCR method for easier and rapid detection of rs12255372 polymorphism without the use of expensive instrumentation and reagents. Our study in a relatively small sample of the Venezuelan population replicated the association of the rs7903146 SNP with T2DM. Further studies with larger sample size and more biochemical data should be conducted to explore the genetic basis of T2DM susceptibility in Venezuela.


Asunto(s)
Alelos , Diabetes Mellitus Tipo 2/genética , Técnicas de Genotipaje/métodos , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo de Nucleótido Simple/genética , Proteína 2 Similar al Factor de Transcripción 7/genética , Adulto , Estudios de Casos y Controles , Diabetes Mellitus Tipo 2/etnología , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Marcadores Genéticos , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Polimorfismo de Longitud del Fragmento de Restricción , Reproducibilidad de los Resultados , Factores de Riesgo , Venezuela
4.
Arch. endocrinol. metab. (Online) ; 60(3): 246-251, tab, graf
Artículo en Inglés | LILACS | ID: lil-785232

RESUMEN

Objective The global burden of diabetes mellitus will impact strongly American countries in the coming decades. Type 2 diabetes mellitus (T2DM) is a multifactorial disease and the basis for its genetic susceptibility remains not fully understood. Different population studies have demonstrated that variants of the TCF7L2 gene are strongly associated with an increased risk of T2DM. Moreover, institutions or countries with limited budget to conduct genetic research need cost effective methods for detecting DNA variants. Subjects and methods We standardized a rapid and simple allele-specific PCR method for genotyping the rs12255372 single nucleotide polymorphism (SNP) in a pilot study exploring the association of three TCF7L2 polymorphisms (rs7903146, rs12255372 and DG10S478) with T2DM in 70 patients and 73 controls from Venezuela. Results The performance of the designed allele-specific PCR reaction for rs12255372 genotyping was reliable and accurate. Patients carrying the TCF7L2 rs7903146 T allele (CT + TT genotypes) and heterozygous CT genotype had a significantly higher risk for T2DM (OR = 2.9 and 2.3, respectively). Although rs12255372 and DG10S478 risk alleles predominated in T2DM group no statistical significance was found. Conclusions We developed a novel allele-specific PCR method for easier and rapid detection of rs12255372 polymorphism without the use of expensive instrumentation and reagents. Our study in a relatively small sample of the Venezuelan population replicated the association of the rs7903146 SNP with T2DM. Further studies with larger sample size and more biochemical data should be conducted to explore the genetic basis of T2DM susceptibility in Venezuela.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo de Nucleótido Simple/genética , Diabetes Mellitus Tipo 2/genética , Alelos , Proteína 2 Similar al Factor de Transcripción 7/genética , Técnicas de Genotipaje/métodos , Venezuela , Polimorfismo de Longitud del Fragmento de Restricción , Marcadores Genéticos , Estudios de Casos y Controles , Proyectos Piloto , Reproducibilidad de los Resultados , Factores de Riesgo , Diabetes Mellitus Tipo 2/etnología , Estudios de Asociación Genética , Frecuencia de los Genes
5.
Invest. clín ; 50(2): 153-161, jun. 2009. ilus, tab
Artículo en Español | LILACS | ID: lil-564812

RESUMEN

El polimorfismo del codón 72 del gen TP53 ha sido asociado con un riesgo elevado para el desarrollo de cáncer. Este polimorfismo origina dos variantes de la proteína, una con un residuo de Arginina (CGC), y otra con Prolina (CCC). El objetivo del estudio fue analizar la asociación de este polimorfismo con el riesgo de desarrollar cáncer gástrico en individuos procedentes de la región centroccidental de Venezuela, considerada de alto riesgo para esta neoplasia maligna. El ADN fue extraído de biopsias de adenocarcinoma gástrico incluídas en parafina (n = 65) y biopsias endoscópicas de pacientes con gastritis crónica (n = 87). El polimorfismo del codón 72 de TP53 fue determinado por PCR-RFLP. Se observó un incremento significativo de la frecuencia del alelo Arg en los pacientes con cáncer gástrico (P = 0,037), originando un riesgo 4,6 veces mayor (95% IC 1,0-21,3) de desarrollar esta enfermedad. Se evidenció un incremento del genotipo Arg/Arg en adenocarcinoma gástrico poco diferenciado (OR: 3,1; 95% IC 1,0-9,2), y del genotipo Arg/Pro en adenocarcinoma de moderado/buen grado de diferenciación (OR: 3,5; 95% IC 1,1-11,0) al comparar con el grupo de cáncer gástrico, y este último también al contrastar con los individuos con gastritis crónica (OR: 2,4; 95% IC 1,1-5,2). Los resultados de este estudio sugieren que la condición de portador del alelo Arg podría estar asociado con el desarrollo de cáncer gástrico en esta región de Venezuela.


Codon 72 polymorphism of the tumor suppressor gene TP53 has been associated with a higher risk in the development of several types of cancer. The polymorphism results in a variant protein with either an arginine (CGC) or a proline residue (CCC). The aim of this study was to analyze the association of the TP53 codon 72 polymorphism with the risk of developing gastric cancer in a high-risk population from the central-western region of Venezuela. DNA was extracted from paraffin-embedded gastric adenocarcinoma biopsies (n = 65) and endoscopic biopsies from chronic gastritis patients (n = 87). TP53 codon 72 polymorphism was determined by PCR-RFLP from all samples. Patients with gastric cancer had a significantly higher frequency (P = 0.037) of the Arg allele than those with chronic gastritis. A logistic regression analysis suggested that Arg carrier individuals had a 4.6-fold higher risk (95% CI 1.0-21.3) of developing gastric cancer. An increment of the Arg/Arg genotype was observed in poor-differentiated gastric adenocarcinoma (OR: 3.1; 95% CI 1.0-9.2), and of the Arg/Pro genotype in well/ moderate-differentiated adenocarcinoma samples (OR: 3.5; 95% CI 1.1-11.0), when comparing within the gastric cancer samples; and the last group also when contrasting it with chronic gastritis patients (OR: 2.4; 95% CI 1.1-5.2). The results of this study suggest that the carriage of the Arg allele could be associated with the development of gastric cancer in this Venezuelan population.


Asunto(s)
Humanos , Masculino , Femenino , Adenocarcinoma/patología , Biopsia/métodos , Codón/efectos adversos , Polimorfismo Genético , Neoplasias Gástricas , Oncología Médica
6.
Invest. clín ; 48(4): 485-493, dic. 2007. ilus, graf
Artículo en Español | LILACS | ID: lil-486585

RESUMEN

Los telómeros son complejos nucleoproteicos que protegen los extremos de cromosomas eucariotas de fenómenos de degradación y recombinación. En humanos, los telómeros miden 10-12 kpb en células somáticas normales, pero pueden reducirse hasta apenas 1-2 kpb en células tumorales de rápido crecimiento, debido a la replicación incompleta de estas estructuras en cada división mitótica. Los telómeros se acortan con la edad, lo cual puede estar asociado a inestabilidad genómica y a un incremento del riesgo de sufrir cáncer. El análisis de fragmentos de restricción teloméricos por Southern blot es en la actualidad el método estándar para la medición de la longitud de los telómeros. Sin embargo, una determinación precisa no es posible cuando el ADN está fragmentado o es escaso, como es el caso de las biopsias incluidas en parafina. En este trabajo se adecuó un ensayo de slot blot para cuantificar el contenido relativo, en lugar de la longitud, del ADN telomérico a partir de muestras de archivo de adenocarcinoma de colon. El contenido de ADN telomérico pudo ser medido de manera reproducible con apenas 75 ng de ADN genómico altamente degradado empleando detección de la hibridización por quimioluminiscencia.


Asunto(s)
Humanos , Adenocarcinoma , Biopsia , Cromosomas , Neoplasias del Colon/patología , Oncología Médica , Venezuela
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA